Stress Systems and Psychotherapy in Depression (Bio-COPE)
Primary Purpose
Major Depressive Episode
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
internet-based intervention for mild to moderate depression
Sponsored by

About this trial
This is an interventional treatment trial for Major Depressive Episode focused on measuring major depressive episode, cortisol, alpha-amylase, psychotherapy
Eligibility Criteria
Inclusion Criteria:
- Current major depressive episode (F32.0, F32.1, F33.0, F33.1)
- Agreement to participate in the study
- At least 18 years of age
Exclusion Criteria:
- Diagnosis of schizophrenia, schizotypal and delusional disorders (F20-F29)
- Acute suicidal patients
- Acute manic episode
- Substance related abuse or addiction
- Pregnancy or lactation
- Chronic somatic diseases
- Severe somatic diseases (e.g., endocrinological, neurological, autoimmune diseases)
- Glucocorticoid medication intake during the last six months
- Concurrent psychotherapeutic treatment
Sites / Locations
- Freie Universitaet Berlin
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
iCBT for depression - behavioral activation first (BAF)
iCBT for depression - cognitive restructuring first (CRF)
Arm Description
internet-based intervention for mild to moderate depression: patients receive behavioral activation first, followed by cognitive restructuring
internet-based intervention for mild to moderate depression: patients receive cognitive restructuring first, followed by behavioral activation
Outcomes
Primary Outcome Measures
Changes in salivary cortisol concentration
Changes in diurnal profiles (six time points: awakening, +30 min., 11am, 2 pm, 6pm, 9pm) of salivary cortisol concentration (nmol/l), measured on two consecutive days, at mid-intervention and post-intervention in responders compared to non-responders to the psychological intervention (assessed by Patient Health Questionnaire (PHQ-9))
Differences in salivary cortisol concentration
Differences in diurnal profiles (six time points: awakening, +30 min., 11am, 2 pm, 6pm, 9pm) of cortisol concentration (nmol/l), measured on two consecutive days, at pre-intervention in responders compared to non-responders to the psychological intervention (assessed by PHQ-9)
Changes in salivary alpha-amylase concentration
Changes in diurnal profiles (six time points: awakening, +30 min., 11am, 2 pm, 6pm, 9pm) of salivary alpha-amylase concentration (U/ml), measured on two consecutive days, at mid-intervention and post-intervention in responders compared to non-responders to the psychological intervention (assessed by Patient Health Questionnaire (PHQ-9))
Differences in salivary alpha-amylase concentration
Differences in diurnal profiles (six time points: awakening, +30 min., 11am, 2 pm, 6pm, 9pm) of salivary alpha-amylase concentration (U/ml), measured on two consecutive days, at pre-intervention in responders compared to non-responders to the psychological intervention (assessed by PHQ-9)
Changes in hair cortisol concentration
Changes in hair cortisol concentrations (nmol/l) at post-intervention in responders compared to non-responders to the psychological intervention (assessed by Patient Health Questionnaire (PHQ-9))
Differences in hair cortisol concentration
Differences in hair cortisol concentrations (nmol/l) at pre-intervention in responders compared to non-responders to the psychological intervention (assessed by PHQ-9)
Secondary Outcome Measures
Sleep quality (self-report)
Changes in Pittsburgh Sleep Quality Index (PSQI); scale ranges from 0 to 21
Chronic stress (self-report)
Changes in Trier Inventory for the assessment of chronic stress - TICS (Trier Inventar zum chronischen Stress), scale ranges from 0 to 48
Cognitive biases (self-report)
Changes in Cognitive Styles Assessment (COSTA-21); scale ranges from 0 to 5 per item
Full Information
NCT ID
NCT03752853
First Posted
November 13, 2018
Last Updated
October 22, 2020
Sponsor
Freie Universität Berlin
1. Study Identification
Unique Protocol Identification Number
NCT03752853
Brief Title
Stress Systems and Psychotherapy in Depression
Acronym
Bio-COPE
Official Title
Biological Correlates of an Internet-based Psychological Intervention for Depression
Study Type
Interventional
2. Study Status
Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
November 20, 2018 (Actual)
Primary Completion Date
August 6, 2020 (Actual)
Study Completion Date
August 6, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Freie Universität Berlin
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis as well as maladaptive activation of the autonomic nervous system (ANS) are discussed as relevant factors in the development of a major depressive episode and as a correlate of its clinical manifestation. Preliminary evidence suggests that the hypercortisolaemic pattern in a subgroup of depressed patients may predict non-responses to psychotherapeutic treatment. At the same time, it is conceivable that disorder-related alterations in HPA axis and ANS regulation change in response to effective treatment, such as cognitive behavioural therapy (CBT), and that those changes could parallel changes in depressive symptoms. Identifying such associations may shed light on biological and psychological mechanisms of action underlying successful treatment.
However, so far, no studies have investigated depressed patients with regard to dysregulation in both stress systems, HPA axis and ANS, before psychotherapeutic treatment, nor have changes in functioning of both systems been inspected in response to treatment. Moreover, a detailed investigation of depressive symptom trajectories over the course of treatment and its associations with changes in HPA axis and ANS regulation is lacking. It can be speculated that specific techniques of the treatment, e.g., typical CBT elements, such as behavioural activation or cognitive restructuring, might particularly be associated with changes in HPA axis and ANS regulation.
The main aims of this project are to investigate:
whether diurnal salivary cortisol and alpha-amylase as well as hair cortisol concentrations change from pre- to post-intervention in treatment responders compared to non-responders;
whether diurnal salivary cortisol and alpha-amylase concentrations change from pre- to mid-intervention and from mid- to post-intervention in treatment responders compared to non-responders;
whether changes in diurnal salivary cortisol, alpha-amylase and hair cortisol concentrations are significantly correlated with changes in depressive symptoms;
whether concentrations of diurnal salivary cortisol and alpha-amylase as well as hair cortisol at pre-treatment predict future treatment response (i.e., on a psychological level).
On an exploratory level, it will be investigated:
which elements of a CBT intervention for depression (behavioural activation vs. cognitive restructuring) are associated with changes in diurnal salivary cortisol and alpha-amylase concentrations.
It is hypothesised:
that pre- to post-intervention decreases in diurnal salivary cortisol and alpha-amylase as well as hair cortisol concentrations will be more pronounced in responders compared to non-responders.
that pre- to mid-intervention and mid- to post-intervention decreases in diurnal salivary cortisol and alpha-amylase will be more pronounced in responders compared to non-responders.
that changes in depressive symptoms will significantly correlate with changes in diurnal cortisol and diurnal alpha-amylase as well as hair cortisol concentrations.
that pre-intervention diurnal salivary cortisol and alpha-amylase as well as hair cortisol concentrations will be higher in future non-responders, compared to responders.
Detailed Description
Recruitment:
Patients will be recruited from an ongoing project providing an internet-based cognitive behavioral intervention for patients suffering from mild to moderate depression.
Protocol:
In this study, a total of N=42 patients fulfilling criteria for a current major depressive episode will undergo a 6-week internet-based cognitive behavioural intervention which consists of seven consecutive modules. Diurnal (salivary) and hair cortisol as well as diurnal (salivary) alpha-amylase will be assessed immediately before and after treatment, and at mid-treatment (i.e., after four of seven modules). Saliva samples (six samples per day) will be collected over two consecutive days. One hair sample will be obtained at pre- and post-intervention assessments respectively.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Major Depressive Episode
Keywords
major depressive episode, cortisol, alpha-amylase, psychotherapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
42 (Actual)
8. Arms, Groups, and Interventions
Arm Title
iCBT for depression - behavioral activation first (BAF)
Arm Type
Experimental
Arm Description
internet-based intervention for mild to moderate depression: patients receive behavioral activation first, followed by cognitive restructuring
Arm Title
iCBT for depression - cognitive restructuring first (CRF)
Arm Type
Experimental
Arm Description
internet-based intervention for mild to moderate depression: patients receive cognitive restructuring first, followed by behavioral activation
Intervention Type
Behavioral
Intervention Name(s)
internet-based intervention for mild to moderate depression
Intervention Description
The six-weeks, therapist-guided, internet-based intervention for depression includes expressive writing tasks and further consists of key elements of cognitive behavioral therapy (CBT) for depression. In seven consecutive modules, patients receive psychoeducation and instructions for weekly tasks, and an individualized feedback letter of their therapist after each module. The intervention is effective in reducing depressive symptoms (Zagorscak et al., 2018). In the current study, patients will be randomly assigned to two different conditions with varying orders of modules: 1. patients will receive two modules (module 3 and 4) of behavioral activation, followed by two modules (modules 5 and 6) of cognitive restructuring; 2. patients will receive two modules (module 3 and 4) of cognitive restructuring, followed by two modules (modules 5 and 6) of behavioral activation. All other modules (1, 2 and 7) will be identical across conditions.
Primary Outcome Measure Information:
Title
Changes in salivary cortisol concentration
Description
Changes in diurnal profiles (six time points: awakening, +30 min., 11am, 2 pm, 6pm, 9pm) of salivary cortisol concentration (nmol/l), measured on two consecutive days, at mid-intervention and post-intervention in responders compared to non-responders to the psychological intervention (assessed by Patient Health Questionnaire (PHQ-9))
Time Frame
pre-intervention, mid-intervention (after an average of three weeks), post-intervention (after an average of six weeks)
Title
Differences in salivary cortisol concentration
Description
Differences in diurnal profiles (six time points: awakening, +30 min., 11am, 2 pm, 6pm, 9pm) of cortisol concentration (nmol/l), measured on two consecutive days, at pre-intervention in responders compared to non-responders to the psychological intervention (assessed by PHQ-9)
Time Frame
pre-intervention
Title
Changes in salivary alpha-amylase concentration
Description
Changes in diurnal profiles (six time points: awakening, +30 min., 11am, 2 pm, 6pm, 9pm) of salivary alpha-amylase concentration (U/ml), measured on two consecutive days, at mid-intervention and post-intervention in responders compared to non-responders to the psychological intervention (assessed by Patient Health Questionnaire (PHQ-9))
Time Frame
pre-intervention, mid-intervention (after an average of three weeks), post-intervention (after an average of six weeks)
Title
Differences in salivary alpha-amylase concentration
Description
Differences in diurnal profiles (six time points: awakening, +30 min., 11am, 2 pm, 6pm, 9pm) of salivary alpha-amylase concentration (U/ml), measured on two consecutive days, at pre-intervention in responders compared to non-responders to the psychological intervention (assessed by PHQ-9)
Time Frame
pre-intervention
Title
Changes in hair cortisol concentration
Description
Changes in hair cortisol concentrations (nmol/l) at post-intervention in responders compared to non-responders to the psychological intervention (assessed by Patient Health Questionnaire (PHQ-9))
Time Frame
pre-intervention, post-intervention (after an average of six weeks)
Title
Differences in hair cortisol concentration
Description
Differences in hair cortisol concentrations (nmol/l) at pre-intervention in responders compared to non-responders to the psychological intervention (assessed by PHQ-9)
Time Frame
pre-intervention
Secondary Outcome Measure Information:
Title
Sleep quality (self-report)
Description
Changes in Pittsburgh Sleep Quality Index (PSQI); scale ranges from 0 to 21
Time Frame
pre-intervention, mid-intervention (after an average of three weeks), post-intervention (after an average of six weeks)
Title
Chronic stress (self-report)
Description
Changes in Trier Inventory for the assessment of chronic stress - TICS (Trier Inventar zum chronischen Stress), scale ranges from 0 to 48
Time Frame
pre-intervention, mid-intervention (after an average of three weeks), post-intervention (after an average of six weeks)
Title
Cognitive biases (self-report)
Description
Changes in Cognitive Styles Assessment (COSTA-21); scale ranges from 0 to 5 per item
Time Frame
pre-intervention, mid-intervention (after an average of three weeks), post-intervention (after an average of six weeks)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Current major depressive episode (F32.0, F32.1, F33.0, F33.1)
Agreement to participate in the study
At least 18 years of age
Exclusion Criteria:
Diagnosis of schizophrenia, schizotypal and delusional disorders (F20-F29)
Acute suicidal patients
Acute manic episode
Substance related abuse or addiction
Pregnancy or lactation
Chronic somatic diseases
Severe somatic diseases (e.g., endocrinological, neurological, autoimmune diseases)
Glucocorticoid medication intake during the last six months
Concurrent psychotherapeutic treatment
Facility Information:
Facility Name
Freie Universitaet Berlin
City
Berlin
ZIP/Postal Code
14195
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
29306945
Citation
Zagorscak P, Heinrich M, Sommer D, Wagner B, Knaevelsrud C. Benefits of Individualized Feedback in Internet-Based Interventions for Depression: A Randomized Controlled Trial. Psychother Psychosom. 2018;87(1):32-45. doi: 10.1159/000481515. Epub 2018 Jan 6.
Results Reference
background
Learn more about this trial
Stress Systems and Psychotherapy in Depression
We'll reach out to this number within 24 hrs